Open AccessLong‑term vonoprazan therapy is effective for controlling symptomatic proton pump inhibitor‑resistant gastroesophageal reflux diseaseOpen AccessAuthor(s)
Satoshi Shinozaki,
Hiroyuki Osawa,
Yoshikazu Hayashi,
Yoshimasa Miura,
Alan Kawarai Lefor,
Hironori Yamamoto
Publication year2021
Publication title
biomedical reports
Resource typeJournals
Subject(s)constipation , diarrhea , disease , gastroenterology , gerd , insulin , medicine , postprandial , proton pump inhibitor , reflux
Language(s)English
SCImago Journal Rank0.607
H-Index25
ISSN2049-9434
DOI10.3892/br.2021.1408
Seeing content that should not be on Zendy? Contact us.